Stealth BioTherapeutics Corp.

Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey with mitochondrial disease and raise awareness of the unmet need our programs seek to address.

Nasdaq: MITO
IR Website:
Headquarters: The Cayman Islands

Content provided by Stealth BioTherapeutics on 2/24/22


The Stealth BioTherapeutics management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.


Investor Presentation

Management Overview

Risks & Disclosures